Management of recurrent pancreatic cancer after surgical resection: a protocol for systematic review, evidence mapping and meta-analysis

INTRODUCTION: Although recurrence rate among cases of resected pancreatic cancer are as high as 85%, an optimal treatment for recurrent pancreatic cancer (RePC) has not been established. Previous evidence regarding RePC is scarce, and randomised controlled trials (RCTs) are particularly lacking. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jong-chan, Ahn, Soyeon, Cho, In Kuk, Lee, Jongchan, Kim, Jaihwan, Hwang, Jin-Hyeok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5892773/
https://www.ncbi.nlm.nih.gov/pubmed/29632079
http://dx.doi.org/10.1136/bmjopen-2017-017249

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5892773/
https://www.ncbi.nlm.nih.gov/pubmed/29632079
http://dx.doi.org/10.1136/bmjopen-2017-017249

Ejemplares similares